Related references
Note: Only part of the references are listed.A gene transcription signature of obesity in breast cancer
Chad J. Creighton et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Catherine Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 Molar Ratio and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Jason B. Douglas et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
Robert G. Maki
JOURNAL OF CLINICAL ONCOLOGY (2010)
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Timothy J. Key et al.
LANCET ONCOLOGY (2010)
Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia
Bernardo Bonanni et al.
CLINICAL CANCER RESEARCH (2009)
Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis
Patrizia Pasanisi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
Chad J. Creighton et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology
Claire M. Perks et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users
Andrea Decensi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
S. R. Heller et al.
DIABETOLOGIA (2007)
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer
Laura Baglietto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
IGF-1, IGFBP-3 and breast cancer risk in women:: The European Prospective Investigation into Cancer and Nutrition (EPIC)
S. Rinaldi et al.
ENDOCRINE-RELATED CANCER (2006)
Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors
ML Irwin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk
NE Allen et al.
BRITISH JOURNAL OF CANCER (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women
A Lukanova et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Circulating levels of insulin-like growth factor I, its binding proteins-1,-2, -3, C-peptide and risk of postmenopausal breast cancer
L Keinan-Boker et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Adiposity and sex hormones in postmenopausal breast cancer survivors
A McTiernan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes
PJ Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden
R Kaaks et al.
CANCER CAUSES & CONTROL (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
M Pollak et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
